Call for Entries - 2008 CURE Extraordinary Healer Award for Oncology Nursing
Cancer patients and caregivers are asked to submit essays nominatingoncology nurses who exemplify these characteristics. Three finalists, andthose who nominated them, will be honored at a special reception during theOncology Nursing Society's Annual Congress in Philadelphia on May 15 at 7pm atthe Philadelphia Downtown Marriott. The call for entries is featured in theWinter 2007 and Spring 2008 issues of CURE, a quarterly magazine for cancerpatients, survivors and caregivers, as well as the Spring issue of HEAL, aquarterly magazine for cancer survivors. Nominations must be received byApril 7, 2008. For more information about the 2008 Extraordinary Healer Awardfor Oncology Nursing, please visit www.curetoday.com.
"Oncology nurses provide a vital service to people affected by cancer, andOrtho Biotech is proud to be part of an effort that recognizes these exemplaryprofessionals," said Craig Tendler, M.D., Vice President, Medical Affairs,Oncology/Nephrology, Ortho Biotech Products, L.P. "Patients rely on a strongnetwork of care while going through cancer treatment, and oncology nursesprovide the critical physical and emotional support patients need to completecancer treatment."
In 2007, CURE received more than 200 essay entries for its inauguralExtraordinary Healer Award for Oncology Nursing, and more than 650 nursesattended the award ceremony at the Oncology Nursing Society's Annual Congress.The winning and finalist essays from 2007 can be read on line atwww.curetoday.com/healeraward2007.
"The Extraordinary Healer Award has given us the opportunity to give avoice back to our readers, who openly share their admiration and appreciationfor their nurses," says Melissa Weber, managing editor of CURE. "The award isa forum for our readers to say thank you, and they're saying it quiteeloquently."
CURE is a quarterly magazine with an annual Resource Guide and specialissue that combines the science and humanity of cancer for those who have todeal with it on a daily basis. CURE provides scientific information ineasy-to-understand language for patients, survivors and caregivers. It ispublished by Dallas-based CURE Media Group, L.P.
About Ortho Biotech Products, L.P.
Ortho Biotech Products, L.P. is a leading biopharmaceutical companydevoted to helping improve the lives of patients with cancer and with anemiadue to multiple causes, including chronic kidney disease. Since it wasfounded in 1990, Ortho Biotech and its worldwide affiliates have earned aglobal reputation for researching, manufacturing and marketing innovativeproducts that enhance patients' health. Located in Bridgewater, N.J., OrthoBiotech is an established market leader in Epoetin alfa therapy for anemiamanagement. The company also markets treatments for recurrent ovarian cancer,rejection of transplanted organs and other serious illnesses. For moreinformation, visit www.orthobiotech.com.
SOURCE Ortho Biotech Products, L.P.
You May Also Like